0|chunk|F1000Research Open Peer Review v2

1|chunk|(0) Comments 2 1 OPINION ARTICLE FDA approved drugs as potential Ebola treatments [v2; ref status: indexed, http://f1000r.es/554] Abstract
1	46	51 drugs	Chemical	CHEBI_23888

2|chunk|In the search for treatments for the Ebola Virus, multiple screens of FDA drugs have led to the identification of several with promising activity. These in vitro compounds were not originally developed as antivirals and some have been further tested in mouse models. We put forward the opinion that some of in vivo these drugs could be evaluated further and move into the clinic as they are already FDA approved and in many cases readily available. This may be important if there is a further outbreak in future and no other therapeutic is available.
2	74	79 drugs	Chemical	CHEBI_23888
2	205	215 antivirals	Chemical	CHEBI_22587
2	321	326 drugs	Chemical	CHEBI_23888

3|chunk|Drugs mobile app http://molmatinf.com/approveddrugs.html. Supplemental Figure 2. Amodiaquine similarity in Approved drugs mobile app http://molmatinf.com/approveddrugs.html. PubMed Abstract | Publisher Full Text 2. Trad MA, Fisher DA, Tambyah PA, et al.: Ebola in west Africa. Lancet Infect Dis. 2014; 14(11): 1045. PubMed Abstract | Publisher Full Text 3. Madrid PB, Chopra S, Manger ID, et al.: A systematic screen of FDA-approved drugs for inhibitors of biological threat agents. PLoS One. 2013; 8(4): e60579. PubMed Abstract | Publisher Full Text | Free Full Text 4. de Wilde AH, Jochmans D, Posthuma CC, et al.: Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture. Antimicrob Agents Chemother. 2014; 58(8): 4875-84. PubMed Abstract | Publisher Full Text | Free Full Text 5. Keyaerts E, Li S, Vijgen L, et al.: Antiviral activity of chloroquine against human coronavirus OC43 infection in newborn mice. Antimicrob Agents Chemother. 2009; 53(8): 3416-21. PubMed Abstract | Publisher Full Text | Free Full Text 6. Vincent MJ, Bergeron E, Benjannet S, et al.: Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virol J. 2005; 2: 69. PubMed Abstract | Publisher Full Text | Free Full Text 7. Boonyasuppayakorn S, Reichert ED, Manzano M, et al.: Amodiaquine, an antimalarial drug, inhibits dengue virus type 2 replication and infectivity. Antiviral Res. 2014; 106: 125-34. PubMed Abstract | Publisher Full Text 8. Johansen LM, Brannan JM, Delos SE, et al.: FDA-approved selective estrogen receptor modulators inhibit Ebola virus infection. Sci Transl Med. 2013; 5(190): 190ra79. PubMed Abstract | Publisher Full Text | Free Full Text 9. Gehring G, Rohrmann K, Atenchong N, et al.: The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entry. J Antimicrob Chemother. 2014; 69(8): 2123-31. PubMed Abstract | Publisher Full Text 10. Ekins S, Freundlich JS, Coffee M, et al.: A common feature pharmacophore for FDA-approved drugs inhibiting the Ebola virus [v2; ref status: indexed, http:// f1000r.es/4wt]. F1000Res. 2014; 3: 277. PubMed Abstract | Publisher Full Text | Free Full Text 11. Veljkovic V, Loiseau PM, Figadere B, et al.: Virtual screen for repurposing approved and experimental drugs for candidate inhibitors of EBOLA virus infection [v2; ref status: indexed, http://f1000r.es/53d]. F1000Res. 2015; 4: 34. Publisher Full Text 12. Kouznetsova J, Sun W, Martnez-Romero C, et al.: Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs. Emerg Microbes Infect. 2014; 3: e84. Publisher Full Text 13. Long J, Wright E, Molesti E, et al.: Antiviral therapies against Ebola and other emerging viral diseases using existing medicines that block virus entry [v2; ref status: awaiting peer review, http://f1000r.es/52g]. F1000Res. 2015; 4: 30. Publisher Full Text 14. Litterman N, Lipinski C, Ekins S, et al.: Small molecules with antiviral activity against the Ebola virus [v1; ref status: indexed, http://f1000r.es/523]. F1000Res. 2015; 4: 38. Publisher Full Text 15. Picazo E, Giordanetto F: Small molecule inhibitors of ebola virus infection. Drug Discov Today. 2015; 20(2): 277-286. PubMed Abstract | Publisher Full Text 16. Yan H, Zhong G, Xu G, et al.: Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. Elife. 2012; 1: Page 5 of 9 F1000Research 2015, 4:48 Last updated: 11 MAR 2015 e00049. PubMed Abstract | Publisher Full Text | Free Full Text 17. Dong Z, Ekins S, Polli JE, et al.: Quantitative NTCP pharmacophore and lack of association between DILI and NTCP Inhibition. Eur J Pharm Sci. 2014; 66C: 1-9. PubMed Abstract | Publisher Full Text 18. Fu LL, Liu J, Chen Y, et al.: In silico analysis and experimental validation of azelastine hydrochloride (N4) targeting sodium taurocholate co-transporting polypeptide (NTCP) in HBV therapy. Cell Prolif. 2014; 47(4): 326-35. PubMed Abstract | Publisher Full Text 19. Blatt J, Farag S, Corey SJ, et al.: Expanding the scope of drug repurposing in pediatrics: the Children's Pharmacy Collaborative. Drug Discov Today. 2014; 19(11): 1696-1698. PubMed Abstract | Publisher Full Text 20. Dyall J, Coleman CM, Hart BJ, et al.: Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection. Antimicrob Agents Chemother. 2014; 58(8): 4885-93. PubMed Abstract | Publisher Full Text | Free Full Text 21. Huang R, Southall N, Wang Y, et al.: The NCGC pharmaceutical collection: a comprehensive resource of clinically approved drugs enabling repurposing and chemical genomics. Sci Transl Med. 2011; 3(80): 80ps16. PubMed Abstract | Publisher Full Text | Free Full Text 22. Oprea TI, Mestres J: Drug repurposing: far beyond new targets for old drugs. AAPS J. 2012; 14(4): 759-63. PubMed Abstract | Publisher Full Text | Free Full Text 23. Walsh CT, Fischbach MA: Repurposing libraries of eukaryotic protein kinase inhibitors for antibiotic discovery. Proc Natl Acad Sci U S A. 2009; 106(6): 1689-90. PubMed Abstract | Publisher Full Text | Free Full Text 24. Dudley JT, Deshpande T, Butte AJ: Exploiting drug-disease relationships for computational drug repositioning. Brief Bioinform. 2011; 12(4): 303-11. PubMed Abstract | Publisher Full Text | Free Full Text 25. Dudley JT, Sirota M, Shenoy M, et al.: Computational repositioning of the anticonvulsant topiramate for inflammatory bowel disease. Sci Transl Med. 2011; 3(96): 96ra76. PubMed Abstract | Publisher Full Text | Free Full Text 26. Ekins S, Williams AJ, Krasowski MD, et al.: In silico repositioning of approved drugs for rare and neglected diseases. Drug Discov Today. 2011; 16(7-8): 298-310. PubMed Abstract | Publisher Full Text 27. Ekins S, Southan C, Coffee M: Finding small molecules for the 'next Ebola' [v1; ref status: awaiting peer review, http://f1000r.es/542].
3	0	5 Drugs	Chemical	CHEBI_23888
3	13	16 app	Chemical	CHEBI_147408
3	81	92 Amodiaquine	Chemical	CHEBI_131327
3	116	121 drugs	Chemical	CHEBI_23888
3	129	132 app	Chemical	CHEBI_147408
3	433	438 drugs	Chemical	CHEBI_23888
3	443	453 inhibitors	Chemical	CHEBI_35222
3	694	704 inhibitors	Chemical	CHEBI_35222
3	708	740 Middle East respiratory syndrome	Disease	DOID_0080642
3	732	740 syndrome	Disease	DOID_225
3	927	936 Antiviral	Chemical	CHEBI_22587
3	949	960 chloroquine	Chemical	CHEBI_3638
3	1173	1184 Chloroquine	Chemical	CHEBI_3638
3	1197	1206 inhibitor	Chemical	CHEBI_35222
3	1210	1214 SARS	Disease	DOID_2945
3	1382	1393 Amodiaquine	Chemical	CHEBI_131327
3	1398	1410 antimalarial	Chemical	CHEBI_38068
3	1411	1415 drug	Chemical	CHEBI_23888
3	1475	1484 Antiviral	Chemical	CHEBI_22587
3	1616	1624 estrogen	Chemical	CHEBI_50114
3	1625	1644 receptor modulators	Chemical	CHEBI_90710
3	1659	1674 virus infection	Disease	DOID_934
3	1841	1846 drugs	Chemical	CHEBI_23888
3	1859	1870 dronedarone	Chemical	CHEBI_50659
3	1875	1884 verapamil	Chemical	CHEBI_9948
3	2093	2098 drugs	Chemical	CHEBI_23888
3	2361	2366 drugs	Chemical	CHEBI_23888
3	2381	2391 inhibitors	Chemical	CHEBI_35222
3	2401	2416 virus infection	Disease	DOID_934
3	2673	2678 drugs	Chemical	CHEBI_23888
3	2778	2787 Antiviral	Chemical	CHEBI_22587
3	3051	3060 molecules	Chemical	CHEBI_25367
3	3066	3075 antiviral	Chemical	CHEBI_22587
3	3236	3244 molecule	Chemical	CHEBI_25367
3	3245	3255 inhibitors	Chemical	CHEBI_35222
3	3265	3280 virus infection	Disease	DOID_934
3	3282	3286 Drug	Chemical	CHEBI_23888
3	3395	3401 Sodium	Chemical	CHEBI_26708
3	3395	3414 Sodium taurocholate	Chemical	CHEBI_36276
3	3402	3414 taurocholate	Chemical	CHEBI_28865
3	3430	3441 polypeptide	Chemical	CHEBI_15841
3	3477	3486 hepatitis	Disease	DOID_2237
3	3477	3488 hepatitis B	Disease	DOID_2043
3	3928	3938 azelastine	Chemical	CHEBI_2950
3	3928	3952 azelastine hydrochloride	Chemical	CHEBI_2951
3	3939	3952 hydrochloride	Chemical	CHEBI_17883
3	3968	3974 sodium	Chemical	CHEBI_26708
3	3968	3987 sodium taurocholate	Chemical	CHEBI_36276
3	3975	3987 taurocholate	Chemical	CHEBI_28865
3	4004	4015 polypeptide	Chemical	CHEBI_15841
3	4174	4178 drug	Chemical	CHEBI_23888
3	4245	4249 Drug	Chemical	CHEBI_23888
3	4405	4410 drugs	Chemical	CHEBI_23888
3	4428	4460 Middle East respiratory syndrome	Disease	DOID_0080642
3	4452	4460 syndrome	Disease	DOID_225
3	4640	4654 pharmaceutical	Chemical	CHEBI_52217
3	4715	4720 drugs	Chemical	CHEBI_23888
3	4882	4886 Drug	Chemical	CHEBI_23888
3	4931	4936 drugs	Chemical	CHEBI_23888
3	5086	5093 protein	Chemical	CHEBI_16541
3	5086	5111 protein kinase inhibitors	Chemical	CHEBI_37699
3	5101	5111 inhibitors	Chemical	CHEBI_35222
3	5116	5126 antibiotic	Chemical	CHEBI_33281
3	5336	5340 drug	Chemical	CHEBI_23888
3	5527	5541 anticonvulsant	Chemical	CHEBI_35623
3	5542	5552 topiramate	Chemical	CHEBI_63631
3	5557	5583 inflammatory bowel disease	Disease	DOID_0050589
3	5761	5766 drugs	Chemical	CHEBI_23888
3	5800	5804 Drug	Chemical	CHEBI_23888
3	5929	5938 molecules	Chemical	CHEBI_25367
3	CHEBI-DOID	CHEBI_23888	DOID_0080642
3	CHEBI-DOID	CHEBI_23888	DOID_225
3	CHEBI-DOID	CHEBI_23888	DOID_2945
3	CHEBI-DOID	CHEBI_23888	DOID_934
3	CHEBI-DOID	CHEBI_23888	DOID_2237
3	CHEBI-DOID	CHEBI_23888	DOID_2043
3	CHEBI-DOID	CHEBI_23888	DOID_0050589
3	CHEBI-DOID	CHEBI_147408	DOID_0080642
3	CHEBI-DOID	CHEBI_147408	DOID_225
3	CHEBI-DOID	CHEBI_147408	DOID_2945
3	CHEBI-DOID	CHEBI_147408	DOID_934
3	CHEBI-DOID	CHEBI_147408	DOID_2237
3	CHEBI-DOID	CHEBI_147408	DOID_2043
3	CHEBI-DOID	CHEBI_147408	DOID_0050589
3	CHEBI-DOID	CHEBI_131327	DOID_0080642
3	CHEBI-DOID	CHEBI_131327	DOID_225
3	CHEBI-DOID	CHEBI_131327	DOID_2945
3	CHEBI-DOID	CHEBI_131327	DOID_934
3	CHEBI-DOID	CHEBI_131327	DOID_2237
3	CHEBI-DOID	CHEBI_131327	DOID_2043
3	CHEBI-DOID	CHEBI_131327	DOID_0050589
3	CHEBI-DOID	CHEBI_35222	DOID_0080642
3	CHEBI-DOID	CHEBI_35222	DOID_225
3	CHEBI-DOID	CHEBI_35222	DOID_2945
3	CHEBI-DOID	CHEBI_35222	DOID_934
3	CHEBI-DOID	CHEBI_35222	DOID_2237
3	CHEBI-DOID	CHEBI_35222	DOID_2043
3	CHEBI-DOID	CHEBI_35222	DOID_0050589
3	DOID-CHEBI	DOID_0080642	CHEBI_22587
3	DOID-CHEBI	DOID_0080642	CHEBI_3638
3	DOID-CHEBI	DOID_0080642	CHEBI_38068
3	DOID-CHEBI	DOID_0080642	CHEBI_50114
3	DOID-CHEBI	DOID_0080642	CHEBI_90710
3	DOID-CHEBI	DOID_0080642	CHEBI_50659
3	DOID-CHEBI	DOID_0080642	CHEBI_9948
3	DOID-CHEBI	DOID_0080642	CHEBI_25367
3	DOID-CHEBI	DOID_0080642	CHEBI_26708
3	DOID-CHEBI	DOID_0080642	CHEBI_36276
3	DOID-CHEBI	DOID_0080642	CHEBI_28865
3	DOID-CHEBI	DOID_0080642	CHEBI_15841
3	DOID-CHEBI	DOID_0080642	CHEBI_2950
3	DOID-CHEBI	DOID_0080642	CHEBI_2951
3	DOID-CHEBI	DOID_0080642	CHEBI_17883
3	DOID-CHEBI	DOID_0080642	CHEBI_52217
3	DOID-CHEBI	DOID_0080642	CHEBI_16541
3	DOID-CHEBI	DOID_0080642	CHEBI_37699
3	DOID-CHEBI	DOID_0080642	CHEBI_33281
3	DOID-CHEBI	DOID_0080642	CHEBI_35623
3	DOID-CHEBI	DOID_0080642	CHEBI_63631
3	DOID-CHEBI	DOID_225	CHEBI_22587
3	DOID-CHEBI	DOID_225	CHEBI_3638
3	DOID-CHEBI	DOID_225	CHEBI_38068
3	DOID-CHEBI	DOID_225	CHEBI_50114
3	DOID-CHEBI	DOID_225	CHEBI_90710
3	DOID-CHEBI	DOID_225	CHEBI_50659
3	DOID-CHEBI	DOID_225	CHEBI_9948
3	DOID-CHEBI	DOID_225	CHEBI_25367
3	DOID-CHEBI	DOID_225	CHEBI_26708
3	DOID-CHEBI	DOID_225	CHEBI_36276
3	DOID-CHEBI	DOID_225	CHEBI_28865
3	DOID-CHEBI	DOID_225	CHEBI_15841
3	DOID-CHEBI	DOID_225	CHEBI_2950
3	DOID-CHEBI	DOID_225	CHEBI_2951
3	DOID-CHEBI	DOID_225	CHEBI_17883
3	DOID-CHEBI	DOID_225	CHEBI_52217
3	DOID-CHEBI	DOID_225	CHEBI_16541
3	DOID-CHEBI	DOID_225	CHEBI_37699
3	DOID-CHEBI	DOID_225	CHEBI_33281
3	DOID-CHEBI	DOID_225	CHEBI_35623
3	DOID-CHEBI	DOID_225	CHEBI_63631
3	CHEBI-DOID	CHEBI_22587	DOID_2945
3	CHEBI-DOID	CHEBI_22587	DOID_934
3	CHEBI-DOID	CHEBI_22587	DOID_2237
3	CHEBI-DOID	CHEBI_22587	DOID_2043
3	CHEBI-DOID	CHEBI_22587	DOID_0050589
3	CHEBI-DOID	CHEBI_3638	DOID_2945
3	CHEBI-DOID	CHEBI_3638	DOID_934
3	CHEBI-DOID	CHEBI_3638	DOID_2237
3	CHEBI-DOID	CHEBI_3638	DOID_2043
3	CHEBI-DOID	CHEBI_3638	DOID_0050589
3	DOID-CHEBI	DOID_2945	CHEBI_38068
3	DOID-CHEBI	DOID_2945	CHEBI_50114
3	DOID-CHEBI	DOID_2945	CHEBI_90710
3	DOID-CHEBI	DOID_2945	CHEBI_50659
3	DOID-CHEBI	DOID_2945	CHEBI_9948
3	DOID-CHEBI	DOID_2945	CHEBI_25367
3	DOID-CHEBI	DOID_2945	CHEBI_26708
3	DOID-CHEBI	DOID_2945	CHEBI_36276
3	DOID-CHEBI	DOID_2945	CHEBI_28865
3	DOID-CHEBI	DOID_2945	CHEBI_15841
3	DOID-CHEBI	DOID_2945	CHEBI_2950
3	DOID-CHEBI	DOID_2945	CHEBI_2951
3	DOID-CHEBI	DOID_2945	CHEBI_17883
3	DOID-CHEBI	DOID_2945	CHEBI_52217
3	DOID-CHEBI	DOID_2945	CHEBI_16541
3	DOID-CHEBI	DOID_2945	CHEBI_37699
3	DOID-CHEBI	DOID_2945	CHEBI_33281
3	DOID-CHEBI	DOID_2945	CHEBI_35623
3	DOID-CHEBI	DOID_2945	CHEBI_63631
3	CHEBI-DOID	CHEBI_38068	DOID_934
3	CHEBI-DOID	CHEBI_38068	DOID_2237
3	CHEBI-DOID	CHEBI_38068	DOID_2043
3	CHEBI-DOID	CHEBI_38068	DOID_0050589
3	CHEBI-DOID	CHEBI_50114	DOID_934
3	CHEBI-DOID	CHEBI_50114	DOID_2237
3	CHEBI-DOID	CHEBI_50114	DOID_2043
3	CHEBI-DOID	CHEBI_50114	DOID_0050589
3	CHEBI-DOID	CHEBI_90710	DOID_934
3	CHEBI-DOID	CHEBI_90710	DOID_2237
3	CHEBI-DOID	CHEBI_90710	DOID_2043
3	CHEBI-DOID	CHEBI_90710	DOID_0050589
3	DOID-CHEBI	DOID_934	CHEBI_50659
3	DOID-CHEBI	DOID_934	CHEBI_9948
3	DOID-CHEBI	DOID_934	CHEBI_25367
3	DOID-CHEBI	DOID_934	CHEBI_26708
3	DOID-CHEBI	DOID_934	CHEBI_36276
3	DOID-CHEBI	DOID_934	CHEBI_28865
3	DOID-CHEBI	DOID_934	CHEBI_15841
3	DOID-CHEBI	DOID_934	CHEBI_2950
3	DOID-CHEBI	DOID_934	CHEBI_2951
3	DOID-CHEBI	DOID_934	CHEBI_17883
3	DOID-CHEBI	DOID_934	CHEBI_52217
3	DOID-CHEBI	DOID_934	CHEBI_16541
3	DOID-CHEBI	DOID_934	CHEBI_37699
3	DOID-CHEBI	DOID_934	CHEBI_33281
3	DOID-CHEBI	DOID_934	CHEBI_35623
3	DOID-CHEBI	DOID_934	CHEBI_63631
3	CHEBI-DOID	CHEBI_50659	DOID_2237
3	CHEBI-DOID	CHEBI_50659	DOID_2043
3	CHEBI-DOID	CHEBI_50659	DOID_0050589
3	CHEBI-DOID	CHEBI_9948	DOID_2237
3	CHEBI-DOID	CHEBI_9948	DOID_2043
3	CHEBI-DOID	CHEBI_9948	DOID_0050589
3	CHEBI-DOID	CHEBI_25367	DOID_2237
3	CHEBI-DOID	CHEBI_25367	DOID_2043
3	CHEBI-DOID	CHEBI_25367	DOID_0050589
3	CHEBI-DOID	CHEBI_26708	DOID_2237
3	CHEBI-DOID	CHEBI_26708	DOID_2043
3	CHEBI-DOID	CHEBI_26708	DOID_0050589
3	CHEBI-DOID	CHEBI_36276	DOID_2237
3	CHEBI-DOID	CHEBI_36276	DOID_2043
3	CHEBI-DOID	CHEBI_36276	DOID_0050589
3	CHEBI-DOID	CHEBI_28865	DOID_2237
3	CHEBI-DOID	CHEBI_28865	DOID_2043
3	CHEBI-DOID	CHEBI_28865	DOID_0050589
3	CHEBI-DOID	CHEBI_15841	DOID_2237
3	CHEBI-DOID	CHEBI_15841	DOID_2043
3	CHEBI-DOID	CHEBI_15841	DOID_0050589
3	DOID-CHEBI	DOID_2237	CHEBI_2950
3	DOID-CHEBI	DOID_2237	CHEBI_2951
3	DOID-CHEBI	DOID_2237	CHEBI_17883
3	DOID-CHEBI	DOID_2237	CHEBI_52217
3	DOID-CHEBI	DOID_2237	CHEBI_16541
3	DOID-CHEBI	DOID_2237	CHEBI_37699
3	DOID-CHEBI	DOID_2237	CHEBI_33281
3	DOID-CHEBI	DOID_2237	CHEBI_35623
3	DOID-CHEBI	DOID_2237	CHEBI_63631
3	DOID-CHEBI	DOID_2043	CHEBI_2950
3	DOID-CHEBI	DOID_2043	CHEBI_2951
3	DOID-CHEBI	DOID_2043	CHEBI_17883
3	DOID-CHEBI	DOID_2043	CHEBI_52217
3	DOID-CHEBI	DOID_2043	CHEBI_16541
3	DOID-CHEBI	DOID_2043	CHEBI_37699
3	DOID-CHEBI	DOID_2043	CHEBI_33281
3	DOID-CHEBI	DOID_2043	CHEBI_35623
3	DOID-CHEBI	DOID_2043	CHEBI_63631
3	CHEBI-DOID	CHEBI_2950	DOID_0050589
3	CHEBI-DOID	CHEBI_2951	DOID_0050589
3	CHEBI-DOID	CHEBI_17883	DOID_0050589
3	CHEBI-DOID	CHEBI_52217	DOID_0050589
3	CHEBI-DOID	CHEBI_16541	DOID_0050589
3	CHEBI-DOID	CHEBI_37699	DOID_0050589
3	CHEBI-DOID	CHEBI_33281	DOID_0050589
3	CHEBI-DOID	CHEBI_35623	DOID_0050589
3	CHEBI-DOID	CHEBI_63631	DOID_0050589

